329 related articles for article (PubMed ID: 26255735)
41. [Safety and efficacy in two-dose vaccination using measles and rubella combined (MR) vaccine].
Terada K; Ouchi K; Ihara T; Okada K; Numazaki K
Kansenshogaku Zasshi; 2008 Sep; 82(5):414-8. PubMed ID: 18975583
[TBL] [Abstract][Full Text] [Related]
42. [Reasons for repeated serologically unsuccessful (HAI-HIG test) rubella vaccination (author's transl)].
Ehrengut W; Florent G
Dtsch Med Wochenschr; 1981 Jul; 106(31-32):987-9. PubMed ID: 7261921
[TBL] [Abstract][Full Text] [Related]
43. [Susceptibility of pregnant women to rubella and the implications of immunization programs].
Villalbí JR; Graells C; Marín T
An Esp Pediatr; 1988 Feb; 28(2):137-40. PubMed ID: 3355032
[TBL] [Abstract][Full Text] [Related]
44. Development of immunoglobulin M-antibodies after rubella immunization with RA27/3 attenuated live vaccine in teen-agers: remaining problems.
Braito A; Fanti O; Rossolini GM; Cellesi C
Boll Ist Sieroter Milan; 1991-1992; 70(1-2):443-8. PubMed ID: 1670047
[TBL] [Abstract][Full Text] [Related]
45. [On vaccination against rubella with live attenuated virus (strain RA 27-3)].
Monaci V; Giovannelli G; Nardi G; Siegert V; Tanzi ML; Bellelli E; Chiusi O
Ann Sclavo; 1974; 16(3):231-42. PubMed ID: 4473961
[No Abstract] [Full Text] [Related]
46. Rubella antibody persistence after immunization.
Herrmann KL; Halstead SB; Wiebenga NH
JAMA; 1982 Jan; 247(2):193-6. PubMed ID: 7053457
[TBL] [Abstract][Full Text] [Related]
47. Antibody response in serum and nasopharynx after naturally acquired and vaccine-induced infection with rubella virus.
Ogra PL; Kerr-Grant D; Umana G; Dzierba J; Weintraub D
N Engl J Med; 1971 Dec; 285(24):1333-9. PubMed ID: 4107718
[No Abstract] [Full Text] [Related]
48. [Test of anti-rubella vaccination with live and attenuated virus (Cendehill strain)].
Leogrande G; Barnaba L; Iandolo E; Iatta E
Minerva Med; 1970 Apr; 61(30 Suppl):1595-8. PubMed ID: 4378365
[No Abstract] [Full Text] [Related]
49. Rubella virus immunization of preschool children via the respiratory tract.
Ganguly R; Durrer B; Waldman RH
Am J Dis Child; 1974 Dec; 128(6):821-3. PubMed ID: 4440651
[No Abstract] [Full Text] [Related]
50. Controlling rubella: problems and perspectives.
Horstmann DM
Ann Intern Med; 1975 Sep; 83(3):412-7. PubMed ID: 1180441
[TBL] [Abstract][Full Text] [Related]
51. [Rubella vaccines (author's transl)].
Rossolini A; Figura N
Ann Sclavo; 1979; 21(6):848-55. PubMed ID: 554555
[TBL] [Abstract][Full Text] [Related]
52. Development of a rubella vaccination strategy: contribution of a rubella susceptibility study of women of childbearing age in Kyrgyzstan, 2001.
Malakmadze N; Zimmerman LA; Uzicanin A; Shteinke L; Caceres VM; Kasymbekova K; Sozina I; Glasser JW; Joldubaeva M; Aidyralieva C; Icenogle JP; Strebel PM; Reef SE
Clin Infect Dis; 2004 Jun; 38(12):1780-3. PubMed ID: 15227627
[TBL] [Abstract][Full Text] [Related]
53. [Problems of rubella prevention: vaccination of 51 fertile young women with the Wister Ra 27/3 virus strain].
Russo F; Piro E; Frugiuele PL; Buffone E; Palma B; Greco LM
Ann Sclavo; 1980; 22(1):57-62. PubMed ID: 7247485
[No Abstract] [Full Text] [Related]
54. Live attenuated rubella virus vaccine in a private pediatric practice.
Nickey LN; Huchton P; Rogers PL
Tex Med; 1973 Feb; 69(2):93-8. PubMed ID: 4734589
[No Abstract] [Full Text] [Related]
55. Clinical trials carried out to assess non-parenteral routes for administration of Wistar RA 27/3 strain live attenuated rubella vaccine.
Freestone DS
Dev Biol Stand; 1976; 33():237-40. PubMed ID: 782973
[TBL] [Abstract][Full Text] [Related]
56. Reducing the global burden of congenital rubella syndrome: report of the World Health Organization Steering Committee On Research Related To Measles and Rubella Vaccines and Vaccination, June 2004.
Best JM; Castillo-Solorzano C; Spika JS; Icenogle J; Glasser JW; Gay NJ; Andrus J; Arvin AM
J Infect Dis; 2005 Dec; 192(11):1890-7. PubMed ID: 16267759
[TBL] [Abstract][Full Text] [Related]
57. [Prepuberal rubella vaccination and development of antibodytiters during five years (author's transl)].
Müller G; Baumann H
Padiatr Padol; 1978; 13(3):291-7. PubMed ID: 673433
[TBL] [Abstract][Full Text] [Related]
58. [Seroprevalence of rubella in Kinshasa (Zaire)].
Omanga U; Goussard B; Kapepela K; Bamba M; Salaun JJ; Piollet M
Bull Soc Pathol Exot; 1991; 84(5 Pt 5):994-1001. PubMed ID: 1819439
[TBL] [Abstract][Full Text] [Related]
59. Serological assessment of measles-rubella vaccination catch-up campaign among university students.
Takeuchi J; Goto M; Kawamura T; Hiraide A
Pediatr Int; 2014 Jun; 56(3):395-9. PubMed ID: 24417932
[TBL] [Abstract][Full Text] [Related]
60. [Accumulative vaccination rate of rubella and positive antibody rate in an area of Japan--future problems with rubella].
Terada K; Niizuma T; Daimon Y; Kataoka N
Kansenshogaku Zasshi; 1999 Oct; 73(10):1038-41. PubMed ID: 10565119
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
